Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) Return on Sales (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Return on Sales for 7 consecutive years, with 0.08% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 3.0% year-over-year to 0.08%, compared with a TTM value of 0.31% through Oct 2025, up 15.0%, and an annual FY2025 reading of 0.32%, up 7.0% over the prior year.
  • Return on Sales was 0.08% for Q4 2025 at VitaNova Life Sciences, up from 0.45% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.41% in Q2 2025 and bottomed at 4.77% in Q4 2023.
  • Average Return on Sales over 5 years is 0.59%, with a median of 0.11% recorded in 2024.
  • The sharpest move saw Return on Sales tumbled -503bps in 2023, then skyrocketed 488bps in 2024.
  • Year by year, Return on Sales stood at 0.33% in 2021, then dropped by -22bps to 0.26% in 2022, then tumbled by -1933bps to 4.77% in 2023, then surged by 102bps to 0.11% in 2024, then fell by -25bps to 0.08% in 2025.
  • Business Quant data shows Return on Sales for YJGJ at 0.08% in Q4 2025, 0.45% in Q3 2025, and 0.41% in Q2 2025.